VaxInnate

About:

VaxInnate is a vaccine company developing cures for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus.

Website: http://www.vaxinnate.com

Top Investors: Wellcome Trust, National Institute of Allergy and Infectious Diseases, New Leaf Venture Partners, Oxford Bioscience Partners, Canaan Partners

Description:

VaxInnate is a vaccine company that focuses on developing cures for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus. It specializes in the fields of healthcare, health diagnostics, and biotechnology. It was founded in 2002 and headquartered in Cranbury, New Jersey.

Total Funding Amount:

$132M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cranbury, New Jersey, United States

Founded Date:

2002-01-01

Contact Email:

skidmorecomm(AT)earthlink.net

Founders:

Michael Sherman

Number of Employees:

51-100

Last Funding Date:

2015-09-28

IPO Status:

Private

Industries: